Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. Income Statement 2016–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 2.0M | 6.2M | 2.8M | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -177.9M | -101.9M | -48.2M | -83.0M | -60.0M | -35.7M | -9.3M |
| EBITDA | — | — | — | -81.1M | -59.1M | -35.4M | -9.3M |
| Net Income | -162.3M | -85.0M | -43.6M | -76.8M | -57.5M | -35.5M | -9.4M |
| Per Share Data | |||||||
| EPS (diluted) | $-4.20 | $-2.55 | $-8.45 | — | — | — | — |
| Shares Outstanding (dil.) | 39M | 33M | 5M | 39M | 33M | 2M | — |
Dianthus Therapeutics Inc. Income Statement — FAQ
Dianthus Therapeutics Inc. (DNTH) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNTH's income statement history?
The chart and table above show Dianthus Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.